← Back to flashcards
SEPT 10 Built from the handwritten pages you uploaded on 10 September 2026.

DKA & HHS

The two hyperglycaemic emergencies side by side — diagnosis, the numbers, and where they are treated differently.

Side by side

DKAHHS
Diabetes typeType 1Type 2
Glucose> 11 mmol/L (often 14–30)> 33 mmol/L (600 mg/dL)
pH< 7.3> 7.3
Bicarbonate< 15 mmol/L> 15 mmol/L
KetonesPresent — ketonaemia > 3 mmol/L or ketonuriaAbsent or minimal
Anion gapRaised (HAGMA)Normal (NAGMA)
OsmolalityNormal or mildly raised> 320–330 mOsm/kg
Sodium125–135 (often low)Pseudohyponatraemia, then high
Volume stateDehydratedProfoundly volume depleted — deficit often 8–10 L
OnsetHoursDays
MortalityLowerHigher

The sodium correction

  • Hyperglycaemia draws water out of cells, diluting the measured sodium — a pseudohyponatraemia.
  • Corrected Na⁺ rises by about 1.5–2 mmol/L for every 5.5 mmol/L (100 mg/dL) that glucose falls.
  • So a "normal" sodium in a patient with a glucose of 40 mmol/L conceals a substantial true hypernatraemia — and the sodium will rise as you treat.
  • A rising corrected sodium during treatment is expected. A falling one means you are giving free water too fast, and risks cerebral oedema.

Treatment targets

Fluid first

  • Fluid resuscitation takes priority over insulin. Insulin without volume worsens hypotension by driving glucose and water intracellularly.
  • 0.9% sodium chloride; the deficit is typically 5–7 L in DKA and greater in HHS.

Insulin

  • Fixed rate 0.1 units/kg/h, continuing the patient's usual long-acting basal insulin.
  • Targets: glucose should fall by 3 mmol/L/h (about 50–70 mg/dL/h) and ketones by 0.5 mmol/L/h, with bicarbonate rising by 3 mmol/L/h.
  • If targets are not met, increase the insulin rate by 1 unit/h.
  • When glucose falls below about 14 mmol/L (250 mg/dL), add glucose 10% alongside — the insulin is being run to clear ketones, not to normalise glucose, so it must not be stopped.

Potassium — the one that kills

  • Total body potassium is always depleted, however the initial figure looks. Acidosis and insulin deficiency have driven potassium out of cells.
  • As soon as insulin starts, potassium crashes. Replace early and measure hourly.
  • If K⁺ < 3.5 mmol/L, do not start insulin until replacement is under way.

When to stop the insulin infusion

  • pH > 7.3, bicarbonate > 18, and no ketones — and the patient is eating and drinking with subcutaneous insulin overlapped before stopping.
  • Do not use glucose alone as the endpoint — glucose normalises long before ketosis resolves.

Cerebral oedema — the commonest cause of death in DKA

  • Particularly in children and young adults, and typically 4–12 hours into treatment.
  • Warning signs: falling GCS · headache · cranial nerve palsy · rising BP with bradycardia (Cushing response) · irritability then drowsiness.
  • Treatment: hypertonic saline 3% at 3–5 ml/kg, or mannitol 0.5–1 g/kg; head up, secure the airway, and slow the fluid.
  • Prevention: correct slowly, avoid overzealous fluid, and do not let the corrected sodium fall.

Anaesthetic implications

  • Both are medical emergencies. Where surgery is the precipitant (sepsis, ischaemic limb, abscess), resuscitate while arranging source control — do not wait for perfect biochemistry, and do not operate on an unresuscitated patient either.
  • Expect gastroparesis, a full stomach and aspiration risk; consider rapid sequence induction.
  • Kussmaul breathing is compensating for the acidosis — if you paralyse and ventilate, match their minute ventilation or the pH will plummet.
  • Watch for hypothermia, hypophosphataemia and hypomagnesaemia, and recheck ketones and potassium frequently.

Quick recall

DKA type 1 · ketones · HAGMA
HHS type 2 · osm >320 · no ketones
Fluid before insulin
0.1 u/kg/h fixed rate
K <3.5 hold insulin
Glucose <14 add 10% dextrose
Na ↑1.5–2 per 100 mg/dL glucose fall
Cerebral oedema commonest death

Built from your DKA/HHS page. Your note gives the DKA glucose threshold as >14 mmol/L (250–300 mg/dL); most current guidance uses >11 mmol/L — and DKA can occur at normal glucose in a patient on an SGLT2 inhibitor.